Alexion Pharmaceuticals (France)

Recent papers from Alexion Pharmaceuticals (France)

1. Real-World Study of Management and Outcomes of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) in FranceAdvances in Therapy · 2026
2. When simulation becomes physical: vicarious symptoms in standardized patients during oscesBMC Medical Education · 2025
3. A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer SurvivorsJournal of Clinical Oncology · 2022
4. The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population‐based haematological malignancy research network 2004‐2018European Journal Of Haematology · 2021
5. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysisBritish Journal of Haematology · 2019
6. Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid LeukemiaJournal of Clinical Oncology · 2019
7. Response Assessment in Neuro-Oncology Clinical TrialsJournal of Clinical Oncology · 2017
8. Impact of cell culture on recombinant monoclonal antibody product heterogeneityBiotechnology Progress · 2016
9. Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE studyCardiology in the Young · 2016
10. Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal HemoglobinuriaNew England Journal of Medicine · 2004
11. Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial InfarctionCirculation · 2003
12. Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial InfarctionCirculation · 2003
13. Myocardial Infarction and Apoptosis After Myocardial Ischemia and ReperfusionCirculation · 1998